220 related articles for article (PubMed ID: 20452131)
21. Approaching the degradome in idiopathic pulmonary fibrosis.
Pardo A; Selman M; Kaminski N
Int J Biochem Cell Biol; 2008; 40(6-7):1141-55. PubMed ID: 18207447
[TBL] [Abstract][Full Text] [Related]
22. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition.
Guarino M; Tosoni A; Nebuloni M
Hum Pathol; 2009 Oct; 40(10):1365-76. PubMed ID: 19695676
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis: clinicopathological correlations.
Calabrese F; Lunardi F; Giacometti C; Marulli G; Gnoato M; Pontisso P; Saetta M; Valente M; Rea F; Perissinotto E; Agostini C
Thorax; 2008 Sep; 63(9):795-802. PubMed ID: 18344408
[TBL] [Abstract][Full Text] [Related]
24. FK506-Binding Protein 10, a Potential Novel Drug Target for Idiopathic Pulmonary Fibrosis.
Staab-Weijnitz CA; Fernandez IE; Knüppel L; Maul J; Heinzelmann K; Juan-Guardela BM; Hennen E; Preissler G; Winter H; Neurohr C; Hatz R; Lindner M; Behr J; Kaminski N; Eickelberg O
Am J Respir Crit Care Med; 2015 Aug; 192(4):455-67. PubMed ID: 26039104
[TBL] [Abstract][Full Text] [Related]
25. Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis.
Korfei M; Skwarna S; Henneke I; MacKenzie B; Klymenko O; Saito S; Ruppert C; von der Beck D; Mahavadi P; Klepetko W; Bellusci S; Crestani B; Pullamsetti SS; Fink L; Seeger W; Krämer OH; Guenther A
Thorax; 2015 Nov; 70(11):1022-32. PubMed ID: 26359372
[TBL] [Abstract][Full Text] [Related]
26. Idiopathic pulmonary fibrosis: an altered fibroblast proliferation linked to cancer biology.
Vancheri C
Proc Am Thorac Soc; 2012 Jul; 9(3):153-7. PubMed ID: 22802290
[TBL] [Abstract][Full Text] [Related]
27. Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis.
Mubarak KK; Montes-Worboys A; Regev D; Nasreen N; Mohammed KA; Faruqi I; Hensel E; Baz MA; Akindipe OA; Fernandez-Bussy S; Nathan SD; Antony VB
Eur Respir J; 2012 Jan; 39(1):133-40. PubMed ID: 21737551
[TBL] [Abstract][Full Text] [Related]
28. Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis.
Machahua C; Montes-Worboys A; Llatjos R; Escobar I; Dorca J; Molina-Molina M; Vicens-Zygmunt V
Respir Res; 2016 Nov; 17(1):144. PubMed ID: 27816054
[TBL] [Abstract][Full Text] [Related]
29. Regulation of 26S Proteasome Activity in Pulmonary Fibrosis.
Semren N; Welk V; Korfei M; Keller IE; Fernandez IE; Adler H; Günther A; Eickelberg O; Meiners S
Am J Respir Crit Care Med; 2015 Nov; 192(9):1089-101. PubMed ID: 26207697
[TBL] [Abstract][Full Text] [Related]
30. Membrane-anchored Serine Protease Matriptase Is a Trigger of Pulmonary Fibrogenesis.
Bardou O; Menou A; François C; Duitman JW; von der Thüsen JH; Borie R; Sales KU; Mutze K; Castier Y; Sage E; Liu L; Bugge TH; Fairlie DP; Königshoff M; Crestani B; Borensztajn KS
Am J Respir Crit Care Med; 2016 Apr; 193(8):847-60. PubMed ID: 26599507
[TBL] [Abstract][Full Text] [Related]
31. Differential mRNA expression of insulin-like growth factor-1 splice variants in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.
Bloor CA; Knight RA; Kedia RK; Spiteri MA; Allen JT
Am J Respir Crit Care Med; 2001 Jul; 164(2):265-72. PubMed ID: 11463599
[TBL] [Abstract][Full Text] [Related]
32. Fibrogenic Lung Injury Induces Non-Cell-Autonomous Fibroblast Invasion.
Ahluwalia N; Grasberger PE; Mugo BM; Feghali-Bostwick C; Pardo A; Selman M; Lagares D; Tager AM
Am J Respir Cell Mol Biol; 2016 Jun; 54(6):831-42. PubMed ID: 26600305
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast.
Gharaee-Kermani M; Hu B; Phan SH; Gyetko MR
Curr Med Chem; 2009; 16(11):1400-17. PubMed ID: 19355895
[TBL] [Abstract][Full Text] [Related]
34. Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis.
Bartis D; Crowley LE; D'Souza VK; Borthwick L; Fisher AJ; Croft AP; Pongrácz JE; Thompson R; Langman G; Buckley CD; Thickett DR
BMC Pulm Med; 2016 Apr; 16(1):51. PubMed ID: 27080864
[TBL] [Abstract][Full Text] [Related]
35. IPF pathogenesis is dependent upon TGFβ induction of IGF-1.
Hernandez DM; Kang JH; Choudhury M; Andrianifahanana M; Yin X; Limper AH; Leof EB
FASEB J; 2020 Apr; 34(4):5363-5388. PubMed ID: 32067272
[TBL] [Abstract][Full Text] [Related]
36. The purinergic receptor subtype P2Y2 mediates chemotaxis of neutrophils and fibroblasts in fibrotic lung disease.
Müller T; Fay S; Vieira RP; Karmouty-Quintana H; Cicko S; Ayata K; Zissel G; Goldmann T; Lungarella G; Ferrari D; Di Virgilio F; Robaye B; Boeynaems JM; Blackburn MR; Idzko M
Oncotarget; 2017 May; 8(22):35962-35972. PubMed ID: 28415591
[TBL] [Abstract][Full Text] [Related]
37. Intracellular Heat Shock Protein 70 Deficiency in Pulmonary Fibrosis.
Sellares J; Veraldi KL; Thiel KJ; Cárdenes N; Alvarez D; Schneider F; Pilewski JM; Rojas M; Feghali-Bostwick CA
Am J Respir Cell Mol Biol; 2019 Jun; 60(6):629-636. PubMed ID: 30543447
[TBL] [Abstract][Full Text] [Related]
38. [A role for mesothelial cells in the genesis of idiopathic pulmonary fibrosis?].
Decologne N; Wettstein G; Bonniaud P
Bull Acad Natl Med; 2010 Feb; 194(2):383-9. PubMed ID: 21166126
[TBL] [Abstract][Full Text] [Related]
39. [Expressions of caveolin-1 and extracellular matrix in lung tissues of patients with idiopathic pulmonary fibrosis].
Wang XF; Ding H; Zhou FQ; Meng FQ; Cai HR
Zhonghua Jie He He Hu Xi Za Zhi; 2012 May; 35(5):336-9. PubMed ID: 22883991
[TBL] [Abstract][Full Text] [Related]
40. Treatments in idiopathic pulmonary fibrosis: time for a more targeted approach?
Mahendran S; Sethi T
QJM; 2012 Oct; 105(10):929-34. PubMed ID: 22647761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]